Anti-oxLDL Antibody (Orticumab)
Catalog No.
F1449
Anti-oxLDL Antibody (Orticumab)
Featured Products
Orticumab (MLDL1278A) is a novel biopharmaceutical targeting oxidized or malondialdehyde-modified lipoproteins (LDLOrticumab specifically inhibits oxidized low-density lipoprotein (oxLDL). Orticumab is involved in regulating the autoimmune response to oxLDL and can improve atherosclerosis in animal models. Orticumab can also be used in studies to improve psoriasis.
145 kDa
Dry ice
1314241-10-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Anti-oxLDL, RG7418, BI-204
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Human
Unconjugated
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
oxLDL
Please avoid freeze-thaw cycles.